User profiles for Xiya Ma
 | Xiya MaUniversité de Montréal Verified email at umontreal.ca Cited by 493 |
[HTML][HTML] Critical care capacity during the COVID-19 pandemic: global availability of intensive care beds
X Ma, D Vervoort - Journal of critical care, 2020 - ncbi.nlm.nih.gov
1. Background As the COVID-19 pandemic grows, the need for rapid, innovative, and cost-effective
emergency response mechanisms and the presence of gaps in critical care capacity …
emergency response mechanisms and the presence of gaps in critical care capacity …
[HTML][HTML] Emergency and essential surgical healthcare services during COVID-19 in low-and middle-income countries: a perspective
The COVID-19 pandemic resulted in significant changes in health care systems worldwide,
with low- and middle-income countries (LMIC) sustaining important repercussions. …
with low- and middle-income countries (LMIC) sustaining important repercussions. …
Money down the drain: predatory publishing in the COVID-19 era
Dear Editor: For years, predatory journals have exploited authors by soliciting papers through
email and social media, offering to publish articles open access quickly and with minimal …
email and social media, offering to publish articles open access quickly and with minimal …
The impact of the COVID-19 pandemic on wellness among vascular surgeons
The coronavirus disease 2019 (COVID-19) pandemic has placed significant strain on the
health and welfare of all health care professionals, including vascular surgeons. This review …
health and welfare of all health care professionals, including vascular surgeons. This review …
[HTML][HTML] Transplantation of tissue-engineered human corneal endothelium in cat models
T Fan, X Ma, J Zhao, Q Wen, X Hu, H Yu, W Shi - Molecular Vision, 2013 - ncbi.nlm.nih.gov
Purpose To evaluate the performance of reconstructed tissue-engineered human corneal
endothelium (TE-HCE) by corneal transplantation in cat models. Methods TE-HCE …
endothelium (TE-HCE) by corneal transplantation in cat models. Methods TE-HCE …
Efficacy and safety of anlotinib in advanced non-small cell lung cancer: a real-world study
K Zhang, X Ma, H Gao, H Wang, H Qin… - Cancer management …, 2020 - Taylor & Francis
Purpose The ALTER0303 trial showed that anlotinib, a novel antiangiogenic tyrosine kinase
inhibitor, administered as third-line or further treatment prolonged progression-free survival (…
inhibitor, administered as third-line or further treatment prolonged progression-free survival (…
COVID-19 pandemic: a time for collaboration and a unified global health front
Coronavirus disease 2019 has, in the span of weeks, immobilized entire countries and
mobilized leading institutions worldwide in a race towards treatments and preventions. Although …
mobilized leading institutions worldwide in a race towards treatments and preventions. Although …
Equitable open access publishing: changing the financial power dynamics in academia
The growth in open access publishing in academia benefits readership but disproportionally
hinders unfunded or lesser-funded researchers. Few journals create comprehensive means …
hinders unfunded or lesser-funded researchers. Few journals create comprehensive means …
[HTML][HTML] Establishment of a continuous untransfected human corneal endothelial cell line and its biocompatibility to denuded amniotic membrane
T Fan, J Zhao, X Ma, X Xu, W Zhao, B Xu - Molecular Vision, 2011 - ncbi.nlm.nih.gov
Purpose To establish an untransfected human corneal endothelial (HCE) cell line and
characterize its biocompatibility to denuded amniotic membrane (dAM). Methods Primary culture …
characterize its biocompatibility to denuded amniotic membrane (dAM). Methods Primary culture …
Rapid scholarly dissemination and cardiovascular community engagement to combat the infodemic of the COVID-19 pandemic
To the Editor: While the body of literature on the novel coronavirus disease 2019 (COVID-19)-related
cardiac complications rapidly expands alongside the exponential surge of …
cardiac complications rapidly expands alongside the exponential surge of …
